Collaboration can provide benefits to the individual and the group across a variety of contexts. Even in simple perceptual tasks, the aggregation of individuals' personal information can enable enhanced group decision-making. However, in certain circumstances such collaboration can worsen performance, or even expose an individual to exploitation in economic tasks, and therefore a balance needs to be struck between a collaborative and a more egocentric disposition. Neurohumoral agents such as oxytocin are known to promote collaborative behaviours in economic tasks, but whether there are opponent agents, and whether these might even affect information aggregation without an economic component, is unknown. Here, we show that an androgen hormone, testosterone, acts as such an agent. Testosterone causally disrupted collaborative decision-making in a perceptual decision task, markedly reducing performance benefit individuals accrued from collaboration while leaving individual decision-making ability unaffected. This effect emerged because testosterone engendered more egocentric choices, manifest in an overweighting of one's own relative to others' judgements during joint decision-making. Our findings show that the biological control of social behaviour is dynamically regulated not only by modulators promoting, but also by those diminishing a propensity to collaborate.
Collaborative efforts, for example, when lions hunt in prides or human scientists toil together in the laboratory, can provide benefits to the individual and the wider social group [1–3]. In perceptual decisions, human groups can achieve a performance benefit by combining individuals' information , and the potential for benefits from such information aggregation by groups is an important concept in disciplines like political science . Similar benefits from collaboration can accrue to groups in tasks assaying intelligence , and collaborative efforts also underlie many cooperative behaviours in choices over the division of resources such as food or money [1,7]. However, a tension exists between collaborative and more self-oriented behaviours: for example, while groups may benefit from a collective intelligence  they can be subject to problems such as ‘group-think’ . Previous work on biological factors influencing this balance has identified factors that promote collaboration (e.g. the hormone oxytocin  and neural reward mechanisms [10,11]). Instead, here we test whether a candidate agent, the hormone testosterone, can diminish collaboration.
Testosterone is implicated in a variety of social behaviours, and these data point to a potential to diminish collaboration. Higher endogenous testosterone correlates with increased anti-social behaviour in female prisoners , higher aggression  and more punitive reactions to unfair offers in a bargaining game . Consistent with a potential to disrupt social collaboration, administering exogenous testosterone decreases facial mimicry as measured by facial muscle responses to photographs of emotional faces ; decreases the ability to infer emotional states from photographs of eyes ; and decreases ratings of trustworthiness in photographs of faces . It has been argued that such findings reflect a more general role for testosterone in increasing a motivation to dominate others (i.e. achieve or maintain social status) [18,19]. Increased status-seeking would in turn predict decreased collaboration in that it entails that individuals, by being more assertive, may be less willing to take account of the opinions of others.
However, when identifying testosterone's effects on social choice, it is important to have a control for testosterone's effects on non-social decision making. In individual choice, endogenous testosterone in men and women has been correlated with psychological variables such as attention  and economic variables, such as risk-taking . Administering exogenous testosterone has widespread effects on non-social cognition, for example on working memory , spatial memory  and reward processing . In particular, testosterone's known associations with reward-related processing [21,24,25] can complicate the interpretation of its effects in traditional economic tasks assaying social choice . These concerns motivate a focus here both on collaborative decision-making without an economic dimension, and also on the need to dissociate testosterone's potential effects on social and individual choice.
To isolate the impact of testosterone on collaborative and individual decision-making, we exploited a task that assays each of these components independently . In our task, individuals must share information, and actively collaborate, to gain a performance benefit in a visual perceptual decision task. The task was performed by pairs of participants (dyads) who initially made a perceptual decision alone, enabling us to measure the sensitivity of each individual's non-social decision-making by estimating the slope (Sindiv) of their psychometric function (figure 1). Then, in trials where the dyad's initial responses diverged, one participant announced a collective decision (agreed on via direct verbal negotiation between dyad members), providing a psychometric function for the dyad (Scollective) that reflected collaborative sensitivity. To successfully collaborate, individuals must appropriately weight their own opinion and that of the others prior to a joint decision . We were agnostic about testosterone's potential effects on individual decisions, but predicted that testosterone would causally disrupt collective decision-making.
Seventeen pairs of participants (dyads) comprised our study sample (mean age 21.7 years, range 18–30; one further dyad was excluded for below-chance behavioural performance). We confined our sample to women, in whom prior evidence links behaviour to both endogenous [12,13,21] and exogenous testosterone [17,26]. All 34 participants were healthy, had normal or corrected to normal visual acuity, took no medication other than long-standing contraceptives (seven took combined oestrogen and progestogen contraception; one took progestogen only contraception), reported regular menstrual cycles (29.1 ± s.d. 2.2 days, range 29–35 days) and were tested between days 1 and 14 of their cycle. All gave informed consent and were paid for attendance.
(b) Experimental procedure
In a randomized, placebo-controlled, double-blind, cross-over design, 80 mg testosterone undecanoate was administered orally (Restandol testocaps; figure 1a). Oral testosterone undecanoate is widely used clinically and has well-known pharmacokinetics [27–29], such that all participants consumed breakfast to aid drug absorption; and the gap between drug administration and the start of behavioural testing was 6–7 h. On two separate days (mean 5.9 days apart, range 3–7 days), the dyad attended at 08.45 when both members received either testosterone or placebo and returned at 15.00 for behavioural testing (figure 1b).
Blood samples were taken on each attendance at the laboratory. Total serum testosterone was measured with a standard, commercially available Roche Modular testosterone assay using electrochemiluminescence immunoassay methods in the University College London Hospitals biochemistry laboratory. Biochemical data were available from 14 of the 17 dyads, with hormonal data from the remaining three dyads incomplete owing to administrative errors in the biochemistry laboratory.
(c) Behavioural methods
In our task, both dyad members sat in a room and performed a 2-alternative forced choice task on identical stimuli presented on separate monitors (figure 1c and see the electronic supplementary material for full details). On each trial, there were two intervals and participants initially decided alone in which interval a target (a higher contrast grating) appeared. Target contrast varied between trials, enabling us to measure the sensitivity of each individual's non-social decision-making by estimating the slope (Sindiv) of their psychometric function (figure 1d), which was determined using standard methods ( and see the electronic supplementary material for details) by plotting the proportion of trials in which the target was reported in the second interval against the contrast difference at the target location (the contrast in the second interval minus the contrast in the first). A large slope indicated highly sensitive performance. After these initial individual decisions, participants then saw their partner's choice. In trials where the dyad's initial responses diverged, one participant was randomly selected to announce a collaborative decision reached after free discussion. As was the case for individuals, we derived a psychometric function for the dyad, where collaborative success was reflected in the slope (Scollective). Feedback either followed the individual decision if they initially agreed, or alternatively followed their joint decision.
(d) Data analysis
Statistical tests were carried out using paired or independent sample t-tests or mixed analyses of variance (ANOVA) in SPSS v. 17.0; reported p-values are two-tailed.
As expected, our hormonal manipulation engendered a large increase in total serum testosterone when comparing the time of behavioural testing (mean 9.3 ± s.d. 9.0 nmol l–1) with either morning baseline (1.2 ± s.d. 0.5; paired t-test t27 = 4.7, p < 0.0001) or placebo (1.1 ± s.d. 0.6; paired t-test t19 = 4.2, p < 0.001). Crucially, testosterone administration had no effect on individual decision-making. Individual sensitivity (Sindiv) under testosterone was no different from placebo when all 34 participants were considered (Sindiv; placebo 3.11 ± s.d. 1.68; testosterone: 2.99 ± s.d. 1.76; paired t-test t33 = 0.5, p > 0.6). This was also the case when considering either the better (Smax placebo 3.80 ± s.d. 1.70; Smax testosterone 3.69 ± s.d. 1.88; paired t-test t16 = 0.2, p > 0.8) or worse performing member of each dyad (Smin placebo 2.41 ± s.d. 1.38; Smin testosterone 2.28 ± s.d. 1.33; paired t-test t16 = 0.5, p > 0.6). The proportion of trials where the dyad's initial decisions diverged also remained unaffected by testosterone (placebo 0.37 ± s.d. 0.10; testosterone 0.39 ± s.d. 0.08; paired t-test t16 = 0.9, p > 0.4).
Having shown that testosterone did not compromise individual decisions, we could then ask if it had a selective impact on the ability to successfully share information. The logic of effective collaboration is that, if achievable, it benefits the individuals more than acting alone [1–3]. We tested this by asking if testosterone affected the performance benefit each individual accrued from working together, measured by Scollective – Sindiv (figure 2). We found that testosterone caused a marked decrease in the individual performance benefit arising from collaboration (Scollective – Sindiv placebo 1.13 ± s.d. 1.33, testosterone 0.54 ± s.d. 1.02; paired t-test t33 = 3.3, p < 0.005). Furthermore, testosterone disrupted the benefit of collaboration for the better participant (Scollective – Smax placebo 0.44 ± s.d. 1.14, testosterone −0.17 ± s.d. 0.59; paired t-test t16 = 2.2, p < 0.05) as well as for the worse participant in each dyad (Scollective – Smin placebo 1.82 ± s.d. 1.15, testosterone 1.24 ± s.d. 0.86; paired t-test t16 = 2.4, p < 0.05). Thus, even from a purely self-interested point of view both dyad members were handicapped when testosterone disrupted the performance benefits from collaboration.
In an evolutionary framework [2,7], our data implicate testosterone as a proximate, mechanistic modulator of collaboration, and specifically one that reduces the ability to collaborate. On this basis, we would expect testosterone to disrupt collaboration via a consistent bias in collaborative decision-making. To test this prediction, we focused on participants' responses as they announced collaborative decisions, where they must appropriately weight each dyad member's opinion. Two considerations might explain how testosterone interferes with this weighting. First, testosterone could lead to a consistent overweighting of the other's opinion, engendering allocentric (other-centred) decision-making, in line with its effect of increasing offers when given in a bargaining game . Second, it could cause consistent overweighting of participants' own opinions, where such egocentricity parallels its effects on trade-offs in animals, for example to eschew parental responsibilities and increase courtship [31,32].
To arbitrate between these competing hypotheses, we computed an egocentric–allocentric (E–A) ratio of the number of trials where the announcer agreed with themselves to the number they agreed with the other. Each hypothesis makes a clear prediction: an allocentricity bias decreases the E–A ratio; and an egocentricity bias increases the E–A ratio. Our data fitted predictions from the second hypothesis, namely that testosterone consistently causes an egocentricity bias (figure 3). The E–A ratio increased under testosterone (1.61 ± s.d. 1.17) relative to placebo (1.26 ± s.d. 0.83; paired t-test t33 = 2.4, p < 0.05). This increased E–A ratio was consistent across both the best and worst-performing dyad members, as shown in a 2 decision-maker (Smin, Smax) by 2 drug (placebo, testosterone) mixed ANOVA in which there was a main effect of drug (F1,16 = 5.8, p < 0.05) but not decision maker (F1,16 = 0.1, p > 0.7) and no interaction (F1,16 = 0.6, p > 0.4). We also note that this egocentricity bias was not accompanied by altered deliberation time for collective decisions (placebo 7.56 s ± s.d. 3.25; testosterone 7.44 ± s.d. 2.89; paired t-test t33 = 0.5, p > 0.6); which in the light of the broader choice literature suggests that the effect was not related to decision uncertainty that is usually accompanied by reaction time changes . Neither E–A ratio nor sensitivity measures were related to total serum testosterone levels (details in the electronic supplementary material). Finally, given a recent study suggesting participants' beliefs about which drug had been administered might affect choice ; we tested for this and found no difference in E–A ratio when participants believed they had received placebo (mean = 1.58 ± s.d. 1.18, n = 44) compared with when they believed they had received testosterone (1.21 ± s.d. 0.62, n = 20; independent samples t-test t62 = 1.3, p > 0.1; details in electronic supplementary material).
In our paradigm, testosterone causally and selectively disrupted individuals' ability to successfully collaborate and aggregate their information in order to achieve a performance benefit. Further, this effect was selective because while disrupting collective decision-making, testosterone left individual decisions unaffected, which is important in the light of testosterone's widespread associations with aspects of non-social choice such as attention , working memory , spatial memory  and reward processing . Finally, we demonstrated that, across both the better and worst-performing members of the dyads, testosterone disrupted collaboration by increasing the egocentricity in individuals' choices, operationalized as an enhanced weighting of one's own relative to another's evidence.
Our finding that testosterone increased egocentric choices accords with a broader literature concerning testosterone's role in social choice, and in particular with an interpretation of that literature which proposes that testosterone's role is to increase dominance or status-related behaviours [18,19]. High social status is associated with elevated testosterone in humans [13,19], chimpanzees  and other mammals . A greater drive for social status leading to greater assertiveness during social interactions might reasonably be expected to impair an individuals' ability to appropriately weight the opinion of another, consistent with our findings. Indeed, the increased egocentricity in an individual's choices that we observe could be interpreted as a form of signalling, whereby the individual is signalling their dominance in the context of a collective decision.
Increased dominance can be detrimental to collaborative decision-making, as shown previously during reasoning tasks where high variance in the verbal contributions of group members (i.e. groups with highly dominant individuals) led to a significantly attenuated performance benefit from collaboration . Other possible effects of testosterone previously related to its role in status-related behaviour  may also contribute to less effective information aggregation in our dyads, for example in reducing trustworthiness ratings of faces  and decreasing the ability to infer emotional states through photographs of eyes . In addition to potential status-related effects of testosterone, our finding of increased egocentricity has interesting parallels with testosterone's role in sexual and reproductive behaviours, where testosterone relates to more self-orientated behaviour as evident in reduced parenting and increased courtship in birds [31,32], rodents  and rural Senegalese men . Importantly, our task involves no conflict over resources as accurate integration of information is in the best interest of the dyad members, which suggests that the effects of testosterone we observed are not caused by it rendering individuals more selfish.
While the idea that testosterone increases status-related or self-orientated behaviours accords well with the wider literature, future work could usefully examine potential causes of this increased egocentricity in choice that are not addressed in our current study. The observation that testosterone did not affect individual choices militates against explanations for more egocentric choices in terms of general motivational  or attentional  effects. Because we did not use monetary rewards, this militates against potential explanations in terms of testosterone's known effects on reward processing, which can explain results in more traditional economic paradigms . However, another potential cause of increased egocentricity in individuals' choices is increased confidence in an individual's own original choices, an idea now testable within a framework that assays meta-cognition . A second possibility is that testosterone disrupts collaboration by reducing an individual's ability to signal their confidence, and future work could extend our design such that only one dyad member received testosterone on each day to ask whether one or both dyad members exhibit a bias. A third possibility is that testosterone might render individuals less susceptible to social influence more generally, a potential cause of more egocentric choices that could be explored in variants of classic experiments such as those described by Asch .
Social animals reap benefits from collaboration across a wide variety of tasks, ranging from those involving information aggregation (as seen here), reasoning  or the division of resources such as food or money [1–3]. Indeed, the potential benefits from information aggregation, for example, are used to support the use of juries (i.e. groups of observers) in the criminal justice system . However, collaborating too freely is not always beneficial, and therefore the biological mechanisms controlling the balance between more collaborative and self-oriented behaviours must dynamically tune behaviour to the social environment. While a previous focus has been on factors promoting collaboration [9–11], here we highlight an opposing biological influence that increases self-orientated or status-related behaviours at the expense of collaboration. Our data show that the humoral agent testosterone modulates the delicate trade-off between collaboration and a more egocentric disposition.
The experiment was approved by the local ethics committee.
C.D.F. is supported by the Danish National Research Foundation, and B.B. by a post-doctoral fellowship from the British Academy, the Danish National Research Foundation, the Danish Research Council for Culture and Communication and the European Union MindBridge project. This work was supported by Wellcome Trust Programme Grant 078865/Z/05/Z to R.J.D. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z. We thank Sanjay Manohar and Ben Pearson for helpful discussions on data analysis.
- Received December 2, 2011.
- Accepted January 11, 2012.
- This journal is © 2012 The Royal Society
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.